New considerations in the design of clinical trials for amyotrophic lateral sclerosis

por Berry, James D, Cudkowicz, Merit E
Publicado 2011

Outcome measures in amyotrophic lateral sclerosis clinical trials

por Paganoni, Sabrina, Cudkowicz, Merit, Berry, James D
Publicado en Clin Investig (Lond) (2014)

Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?

por Nicholson, Katharine A., Cudkowicz, Merit E., Berry, James D.
Publicado en Neurotherapeutics (2015)

Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral Sclerosi...

por Stipancic, Kaila L., Yunusova, Yana, Berry, James D., Green, Jordan R.
Publicado en J Speech Lang Hear Res (2018)

The diagnostic utility of patient-report and speech-language pathologists’ ratings for detecting the early onset of bulbar symptoms due to ALS

por Allison, Kristen M., Yunusova, Yana, Campbell, Thomas F., Wang, Jun, Berry, James D., Green, Jordan R.
Publicado en Amyotroph Lateral Scler Frontotemporal Degener (2017)

Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis

por Stipancic, Kaila L., Yunusova, Yana, Campbell, Thomas F., Wang, Jun, Berry, James D., Green, Jordan R.
Publicado en Front Neurol (2021)

Assessing Oromotor Capacity in ALS: The Effect of a Fixed-Target Task on Lip Biomechanics

por Eshghi, Marziye, Stipancic, Kaila L., Mefferd, Antje, Rong, Panying, Berry, James D., Yunusova, Yana, Green, Jordan R.
Publicado en Front Neurol (2019)

FUS is sequestered in nuclear aggregates in ALS patient fibroblasts

por Schwartz, Jacob C., Podell, Elaine R., Han, Steve S. W., Berry, James D., Eggan, Kevin C., Cech, Thomas R.
Publicado 2014

Electrical Impedance Myography (EIM) in the Evaluation of the Tongue Musculature in Amyotrophic Lateral Sclerosis (ALS)

por Shellikeri, Sanjana, Yunusova, Yana, Green, Jordan R., Pattee, Gary L., Berry, James D., Rutkove, Seward B., Zinman, Lorne
Publicado en Muscle Nerve (2015)

Bulbar and speech motor assessment in ALS: Challenges and future directions

por Green, Jordan R., Yunusova, Yana, Kuruvilla, Mili S., Wang, Jun, Pattee, Gary L., Synhorst, Lori, Zinman, Lorne, Berry, James D.
Publicado 2013

Preclinical rodent toxicity studies for long term use of ceftriaxone

por Ratti, Elena, Berry, James D., Greenblatt, David J., Loci, Lorena, Ellrodt, Amy Swartz, Shefner, Jeremy M., Cudkowicz, Merit E.
Publicado en Toxicol Rep (2015)

Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems

por Rong, Panying, Yunusova, Yana, Wang, Jun, Zinman, Lorne, Pattee, Gary L., Berry, James D., Perry, Bridget, Green, Jordan R.
Publicado en PLoS One (2016)

Developing multidisciplinary clinics for neuromuscular care and research

por Paganoni, Sabrina, Nicholson, Katie, Leigh, Fawn, Swoboda, Kathryn, Chad, David, Drake, Kristin, Haley, Kellen, Cudkowicz, Merit, Berry, James D.
Publicado en Muscle Nerve (2017)

Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America

por Bucheli, Miriam E., Calderón, Amelia, Chicaiza, Diana, Franco, Carolina, López, Ricardo, Digga, Elise, Atassi, Nazem, Salameh, Johnny, Berry, James D.
Publicado 2013

Improved stratification of ALS clinical trials using predicted survival

por Berry, James D., Taylor, Albert A., Beaulieu, Danielle, Meng, Lisa, Bian, Amy, Andrews, Jinsy, Keymer, Mike, Ennist, David L., Ravina, Bernard
Publicado en Ann Clin Transl Neurol (2018)

Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study

por Thonhoff, Jason R., Beers, David R., Zhao, Weihua, Pleitez, Milvia, Simpson, Ericka P., Berry, James D., Cudkowicz, Merit E., Appel, Stanley H.
Publicado en Neurol Neuroimmunol Neuroinflamm (2018)

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis

por Green, Jordan R., Allison, Kristen M., Cordella, Claire, Richburg, Brian D., Pattee, Gary L., Berry, James D., Macklin, Eric A., Pioro, Erik P., Smith, Richard A.
Publicado en Br J Clin Pharmacol (2018)

Design and results of a smartphone‐based digital phenotyping study to quantify ALS progression

por Berry, James D., Paganoni, Sabrina, Carlson, Kenzie, Burke, Katherine, Weber, Harli, Staples, Patrick, Salinas, Joel, Chan, James, Green, Jordan R., Connaghan, Kathryn, Barback, Josh, Onnela, Jukka Pekka
Publicado en Ann Clin Transl Neurol (2019)

Reliability and Validity of Speech & Pause Measures during Passage Reading in ALS

por BARNETT, CAROLINA, GREEN, JORDAN R., MARZOUQAH, REEMAN, STIPANCIC, KAILA L., BERRY, JAMES D., KORNGUT, LAWRENCE, GENGE, ANGELA, SHOESMITH, CHRISTEN, BRIEMBERG, HANNAH, ABRAHAO, AGESSANDRO, KALRA, SANJAY, ZINMAN, LORNE, YUNUSOVA, YANA
Publicado en Amyotroph Lateral Scler Frontotemporal Degener (2019)

Smartphone data during the COVID‐19 pandemic can quantify behavioral changes in people with ALS

por Beukenhorst, Anna L., Collins, Ella, Burke, Katherine M., Rahman, Syed Minhajur, Clapp, Margaret, Konanki, Sai Charan, Paganoni, Sabrina, Miller, Timothy M., Chan, James, Onnela, Jukka‐Pekka, Berry, James D.
Publicado en Muscle Nerve (2020)